Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of SOFTMAX CO.,LTD. A complete text table follows the diagram.
Medical software sales rose 65% as new installations and replacement projects accelerated, doubling operating profit to JPY419M.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Reported sales | 1 | 3.8B | 100.0% of reported total |
| Net sales | 2 | 3.8B | Reported six-month total · ¥3.8B |
| Operating profit | 3 | 419M | 10.9% operating margin |
| Operating costs & expenses | 3 | 3.4B | Arithmetic residual to reported operating profit |
| Profit before tax | 4 | 440M | Reported pretax result |
| Softmax rides medical DX demand through a cloud-first record rebound | 3 | 21.5M | New installations and replacement demand accelerated, while cloud delivery, DX implementation and AI development deepen the medical software platform. |
| Net profit attributable to owners | 5 | 305M | Reported parent-company result |
| Tax, attribution & other | 5 | 135M | Arithmetic bridge to owners' profit |
| From | To | Value |
|---|---|---|
| Reported sales | Net sales | 3.8B |
| Net sales | Operating profit | 419M |
| Net sales | Operating costs & expenses | 3.4B |
| Operating profit | Profit before tax | 419M |
| Softmax rides medical DX demand through a cloud-first record rebound | Profit before tax | 21.5M |
| Profit before tax | Net profit attributable to owners | 305M |
| Profit before tax | Tax, attribution & other | 135M |